Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 This is to inform you that the Company has issued duplicate share certificate in respect of Share Certificates reported to be lost by the shareholders. In accordance with Regulation 39(3) of the Regulations, the details of the said share certificates are as given below: Name of the Shareholder Folio no. No. of shares Old Certificate Nos. Distinctive Nos. New Certificate No. Rajni Chawla Jt. Satpal Chawla 21868 100 179486 77114501-77114600 209865 Manoj Kr. Jain 12014 600 93767 - 93772 77530201-77530800 209864 This is for your information and record.
21-03-2023
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 This is to inform you that the Company has received intimation from the shareholders on 11th February, 2023, regarding loss of share certificates. In accordance with Regulation 39(3) of the Regulations, the details of the said share certificates are as given below: Name of the Shareholder Folio no. No. of shares Certificate Nos. Distinctive Nos. Rajni Chawla Jt. Satpal Chawla 21868 100 179486 77114501-77114600 Manoj Kr. Jain 12014 600 93767 - 93772 77530201-77530800 This is for your information and record.
13-02-2023
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Un-Audited Financial Results For The Quarter And Nine Months Ended 31St December, 2022

 This is to inform that the Board of Directors of the Company has, at its meeting held on Wednesday, 8th February, 2023 (i.e. today), inter-alia, considered and approved the Un-audited Financial Results for the quarter and nine months ended 31st December, 2022, along with the Limited Review Report of the statutory auditor. We are enclosing herewith the Un-audited Financial Results for the quarter and nine months ended 31st December, 2022, along with a copy of the Limited Review Report by the Statutory Auditors of the Company. The Board meeting commenced at 3.00 p.m. and ended at 5.30 p.m.
08-02-2023
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 8Th February, 2023

 This is to inform that the Board of Directors of the Company has, at its meeting held on Wednesday, 8th February, 2023 (i.e. today), inter-alia, considered and approved the Un-audited Financial Results for the quarter and nine months ended 31st December, 2022, along with the Limited Review Report of the statutory auditor. We are enclosing herewith the Un-audited Financial Results for the quarter and nine months ended 31st December, 2022, along with a copy of the Limited Review Report by the Statutory Auditors of the Company. The Board meeting commenced at 3.00 p.m. and ended at 5.30 p.m.
08-02-2023
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Board Meeting Intimation for Consider And Approve Unaudited Financial Results For The Quarter And Nine Months Ended 31St December, 2022

 INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that a meeting of the Board of Directors of the Company will be held on Wednesday, 8th February, 2023, to consider and approve, the unaudited financial results for the quarter and nine months ended 31st December, 2022.
23-01-2023
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 In compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, enclosed please find herewith a Certificate dated 5th January, 2023, issued by M/s. Link Intime India Private Limited, Registrar & Share Transfer Agent of the Company, for the quarter ended 31st December, 2022. This is for your information and record.
14-01-2023
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Closure of Trading Window

 Pursuant to the provisions of the Code of Conduct for Prevention of Insider Trading, under SEBI (Prohibition of Insider Trading) Regulations, 2015, it is hereby informed that Trading Window for dealing in shares of the Company, will remain closed with effect from 1st January, 2023 till 48 hours after the declaration of un-audited financial results for the quarter and nine months ending 31st December, 2022. The date of the Board Meeting to consider the un-audited financial results for the quarter and nine months ending 31st December, 2022, shall be intimated separately.
24-12-2022
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 This is to inform you that the Company has issued duplicate share certificate in respect of Share Certificates reported to be lost by the shareholders. In accordance with Regulation 39(3) of the Regulations, the details of the said share certificates are as given below: Name of the Shareholder Folio no. No. of shares Old Certificate Nos. Distinctive Nos. New Certificate No. Baleshwar Sahu 3341 200 31135 - 31136 70533301 - 70533500 209860 Prashant Bhatia Jt. Toni Bhatia 78992 4 194780 194781 194783 195624 6407910 6408008 6408204 6407367 209861 Joginder Singh 17917 600 133574 - 133579 82144001 - 82144600 209863 This is for your information and record.
16-12-2022
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 This is to inform you that the Company has received intimation from a shareholder on 3rd December, 2022, regarding loss of share certificates. In accordance with Regulation 39(3) of the Regulations, the details of the said share certificates are as given below: Name of the Shareholder Folio no. No. of shares Certificate Nos. Distinctive Nos. Prashant Bhatia Jt. Toni Bhatia 78992 4 194780 194781 194783 195624 6407910 6408008 6408204 6407367 This is for your information and record.
05-12-2022
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 This is to inform you that the Company has received intimation from a shareholder on 28th November, 2022, regarding loss of share certificates. In accordance with Regulation 39(3) of the Regulations, the details of the said share certificates are as given below: Name of the Shareholder Folio no. No. of shares Certificate Nos. Distinctive Nos. Joginder Singh 17917 600 133574 - 133579 82144001 - 82144600
29-11-2022
Next Page
Close

Let's Open Free Demat Account